Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.55    0.00 (0.00%)
Bid:
1.55
Ask:
1.93
Spread: 0.38 (24.516%)
Market Cap: £5.44m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
30th Mar 20217:00 amRNSLoan Amendment
29th Mar 20216:21 pmRNSHolding(s) in Company
26th Mar 20217:00 amRNSTrading Update and Notice of Results
25th Jan 20217:00 amRNSYear End Trading Update
18th Jan 20217:00 amRNSHolding(s) in Company
15th Sep 20204:35 pmRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSAppointment of Chief Executive Officer
10th Aug 20207:00 amRNSInterim Results
27th Jul 202011:53 amRNSHolding(s) in Company
7th Jul 20201:47 pmRNSDirector/PDMR Shareholding
2nd Jul 20204:08 pmRNSDirector/PDMR Shareholding
26th Jun 202011:45 amRNSResult of AGM
26th Jun 202011:00 amRNSAGM Statement
2nd Jun 20207:00 amRNSNotice of Annual General Meeting
30th Apr 20204:53 pmRNSHolding(s) in Company
28th Apr 202011:16 amRNSResponse to Share Price Movement
20th Apr 20207:00 amRNSPosting of Results, AGM update and loan amendment
14th Apr 20207:00 amRNSFinal Results
30th Mar 20207:00 amRNSNotice of Results
16th Mar 20207:00 amRNSNotice of Results
3rd Mar 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20207:00 amRNSFurther Year End Trading Update, Milestone Payment
21st Jan 20207:00 amRNSYear End Trading Update
31st Oct 20197:00 amRNSTrading Update and Announcement of Board Changes
25th Jul 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSLaunch of new services powered by TMTpro 16plex
30th Apr 20193:44 pmRNSResult of AGM
30th Apr 20192:30 pmRNSAGM Statement and Q1 Trading Update
2nd Apr 20197:00 amRNSResults and Notice of AGM
14th Mar 20197:00 amRNSNotice of Results
23rd Jan 20197:00 amRNSYear End Trading Update
20th Dec 20187:00 amRNSAppointment of Nominated Adviser and Broker
10th Dec 20189:26 amRNSHolding(s) in Company
26th Nov 20184:38 pmRNSDirector/PDMR Shareholding
23rd Nov 20181:26 pmRNSDirector/PDMR Shareholding
21st Nov 20189:41 amRNSDirector/PDMR Shareholding
16th Nov 20182:35 pmRNSDirector/PDMR Shareholding
14th Nov 201812:10 pmRNSDirector/PDMR Shareholding
9th Nov 20184:34 pmRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSTrading Update
12th Oct 20184:43 pmRNSDirector/PDMR Shareholding
9th Oct 20183:28 pmRNSDirector/PDMR Shareholding
8th Oct 201810:31 amRNSBlock listing Interim Review
4th Oct 20181:42 pmRNSDirector/PDMR Shareholding
1st Oct 20183:39 pmRNSDirector/PDMR Shareholding
21st Sep 20185:10 pmRNSDirector/PDMR Shareholding
12th Sep 20184:18 pmRNSDirector/PDMR Shareholding
7th Sep 20183:43 pmRNSDirector/PDMR Shareholding
14th Aug 201810:04 amRNSHolding(s) in Company
14th Aug 201810:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.